Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park, gives an insider’s take on the opportunities and challenges for pharma companies in the large, innovation-friendly, but often misunderstood, Japanese market.   Japan is the world’s third-largest economy and second-largest pharmaceutical and medtech market, and yet it still holds a reputation as a difficult business…